These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23509569)

  • 1. Integrating a brief pharmacist intervention into practice: Osteoporosis pharmacotherapy assessment.
    Phillips L; Ferguson R; Diduck K; Lamb D; Jorgenson D
    Can Pharm J (Ott); 2012 Sep; 145(5):218-20. PubMed ID: 23509569
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of compliance with osteoporosis treatment guidelines after initiation of a pharmacist-run osteoporosis service at a family medicine clinic.
    Hall LN; Shrader SP; Ragucci KR
    Ann Pharmacother; 2009 Nov; 43(11):1781-6. PubMed ID: 19826096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of pharmacist interventions on osteoporosis management: a systematic review.
    Elias MN; Burden AM; Cadarette SM
    Osteoporos Int; 2011 Oct; 22(10):2587-96. PubMed ID: 21720894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a community pharmacist-directed clinic in improving screening and awareness of osteoporosis.
    Law AV; Shapiro K
    J Eval Clin Pract; 2005 Jun; 11(3):247-55. PubMed ID: 15869555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacist-run anabolic osteoporosis clinic: An abaloparatide descriptive report.
    McGreevy JL; Kane MP; Busch RS; Bakst G; ElDeiry S
    J Am Pharm Assoc (2003); 2019; 59(4):593-597. PubMed ID: 31101442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-led workshops to enhance pharmacotherapy knowledge for medical students.
    Kim S; Willett L; Hughes F; Sunderram J; Walker JA; Shea JA
    Teach Learn Med; 2013; 25(2):118-21. PubMed ID: 23530672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the Effects of Pharmacist Intervention for Adverse Drug Reaction Detection and Exacerbation Avoidance].
    Imaura M; Yamaya T; Uehara N; Mano N; Nagase S; Kimura K; Kanno H; Yamada Y
    Yakugaku Zasshi; 2017; 137(6):767-774. PubMed ID: 28566582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy Literacy and Parental Practice in Use of Over-the-Counter Pediatric Medicines.
    Krajnović D; Ubavić S; Bogavac-Stanojević N
    Medicina (Kaunas); 2019 Mar; 55(3):. PubMed ID: 30917624
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit.
    Malfará M; Pernassi M; Aragon D; Carlotti A
    Int J Clin Pharm; 2018 Jun; 40(3):513-519. PubMed ID: 29603074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact and feasibility of a pharmacist-delivered pharmacotherapy rotation on pediatric resident education.
    LaRochelle JM; Karpinski AC; Desselle B; Chauvin SW
    Med Educ Online; 2021 Dec; 26(1):1955645. PubMed ID: 34344286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial.
    Yuksel N; Majumdar SR; Biggs C; Tsuyuki RT
    Osteoporos Int; 2010 Mar; 21(3):391-8. PubMed ID: 19499272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with integrating pharmacist documenters on cardiac arrest teams to improve quality.
    Heavner MS; Rouse GE; Lemieux SM; Owusu KA; Pritchard D; Yazdi M; Lee LA
    J Am Pharm Assoc (2003); 2018; 58(3):311-317. PubMed ID: 28941721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of pharmacist intervention in an emergency department.
    Pérez-Moreno MA; Rodríguez-Camacho JM; Calderón-Hernanz B; Comas-Díaz B; Tarradas-Torras J
    Emerg Med J; 2017 Aug; 34(8):495-501. PubMed ID: 27920036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.
    Warden BA; Shapiro MD; Fazio S
    Ann Pharmacother; 2019 Dec; 53(12):1214-1219. PubMed ID: 31342786
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacist Screening for Risk of Osteoporosis in Elderly Veterans.
    Salvig BE; Gulum AH; Walters SA; Edwards LB; Fourakre TN; Marvin SC; McKenzie MS; Moseley MV; Ansari IJ
    Consult Pharm; 2016; 31(8):440-9. PubMed ID: 27535079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapy.
    Hall SF; Edmonds SW; Lou Y; Cram P; Roblin DW; Saag KG; Wright NC; Jones MP; Wolinsky FD
    J Am Pharm Assoc (2003); 2017; 57(4):503-509. PubMed ID: 28602783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Pharmacist-Physician Collaboration on Osteoporosis Treatment Rates.
    Bowers BL; Drew AM; Verry C
    Ann Pharmacother; 2018 Sep; 52(9):876-883. PubMed ID: 29642719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacists' role in improving osteoporosis treatment rates among elderly patients with untreated atraumatic fractures.
    Nadrash TA; Plushner SL; Delate T
    Ann Pharmacother; 2008 Mar; 42(3):334-40. PubMed ID: 18303134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist intervention reduces gastropathy risk in patients using NSAIDs.
    Ibañez-Cuevas V; Lopez-Briz E; Guardiola-Chorro MT;
    Pharm World Sci; 2008 Dec; 30(6):947-54. PubMed ID: 18932013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.